|Net Assets||850.31 Mil|
- Last NAV update 5/22/2013 4:00 PM ET
|The investment seeks a positive total return. The fund is a diversified investment that invests substantially all of its investable assets in the GMO Benchmark-Free Allocation Fund (the "Benchmark-Free Allocation Fund"), an investment company managed by Grantham, Mayo, Van Otterloo & Co. LLC ("GMO"). Benchmark-Free Allocation Fund is a fund of funds that invests primarily in shares of other GMO-managed mutual funds ("underlying funds").|
- Year to date performance as of 5/20/2013 8:00 PM ET
|Fund Family||Wells Fargo Advantage|
|Fund Manager||Ben Inker|
|Minimum Initial Purchase||1,000.00|
|Minimum IRA Investment||250.00|
- * Annualized returns
- Performance as of 5/20/2013 8:00 PM ET
|Net Assets||850.31 Mil||747.61 Mil|
|Avg Market Cap||44.99 Bil||25.37 Bil|
|NAME||% NET ASSETS|
|GMO Benchmark-Free Allocation MF||99.45%|
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.